Detection of tumor ALK status in neuroblastoma patients using peripheral blood

New protocols based on ALK-targeted therapy by crizotinib or other ALK-targeting molecules have opened for the treatment of patients with neuroblastoma (NB) if their tumors showed mutation and/or amplification of the ALK gene. However, tumor samples are not always available for analysis of ALK mutat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Combaret, Valérie, Iacono, Isabelle, Bellini, Angela, Bréjon, Stéphanie, Bernard, Virginie, Marabelle, Aurélien, Coze, Carole, Pierron, Gaelle, Lapouble, Eve, Schleiermacher, Gudrun, Blay, Jean Yves
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402069/
https://ncbi.nlm.nih.gov/pubmed/25653133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados